A comparison of hepatitis B seroepidemiology in ten European countries.
about
Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel diseaseWhat is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?Vaccination coverage of children aged 12-23 months in Gaziantep, Turkey: comparative results of two studies carried out by lot quality technique: what changed after family medicine?Prevalence of chronic hepatitis B in South Western Sydney: evaluation of the country of birth method using maternal seroprevalence data.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantationHepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana'a, Yemen.Reducing the risk of hepatitis B virus transfusion-transmitted infectionOpt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot StudyHepatitis B virus burden in developing countries.Substantial decline in hepatitis B virus infections following vaccine introduction in TajikistanOccult hepatitis B virus infection among Egyptian blood donors.The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registryAssessment of Immunization to Hepatitis B Vaccine among Children under Five Years in Rural Areas of Taiz, Yemen.Update on entecavir in the management of severe forms of Hepatitis B.Hepatitis B virus infection in children.A meta-analysis of HBsAg-positive rate among general Chinese populations aged 1--59 years.Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation.Fluctuation of Viremia in Hepatitis B Virus-Infected Healthcare Workers Performing Exposure-Prone Procedures in the Netherlands.Estimating seroprevalence of vaccine-preventable infections: is it worth standardizing the serological outcomes to adjust for different assays and laboratories?Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome.The impact of hepatitis screening on diagnosis and treatment in rheumatoid arthritis.Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007.Serological pattern of Hepatitis B, C, and HIV infections among immigrants in Sicily: epidemiological aspects and implication on public health.
P2860
Q26827444-1A988EEF-3CD3-4F18-B839-14C2B35C42DCQ27687191-9E840C09-8E4A-4A90-980B-E829FFE39A53Q33588649-F26F9F0F-F6A1-4D0F-9CEC-650477B8DB57Q33813930-0079257A-92A6-4F8C-824C-E227E8B1EF55Q34137291-AE165382-396A-49A7-90FE-185CBDB10C34Q34677180-175BD7DA-D9EF-42AA-B607-A3EC0EC70C0EQ34725624-25FB2711-7316-4CEF-AD63-800C35CEF380Q34782331-547F1870-7AEE-4C76-A5C2-C59533F9B470Q35683881-08B001E7-3C67-4543-9295-C14FEC95CF2CQ35953907-44BCD55C-AD2E-49C1-907F-696847E5EA0EQ36269649-90B9D2C8-AECB-408B-8C1A-CD3A03DB0626Q36410313-8583AC16-B46A-4E85-8630-BD19FB5E1F25Q36812851-9B9C2D48-6790-424A-AE5D-85681DAB250AQ37291800-D5723454-E5B7-424A-85EC-0A51D5210EEAQ37711686-C5842891-FE5F-4676-BA7A-9FFAFD517829Q38201711-847C5982-DF50-419E-AA77-232197E2B1C5Q38365905-16674128-41CB-4B56-9A6F-EDAA93F3B71FQ38387329-89513564-1381-40CA-97C4-F3E8E9D2D77AQ39415844-A621423E-53E8-4882-B2ED-F720329048A7Q40667034-8D6741A4-641A-4434-91BA-D1BCE9EF10DBQ41650697-C444EC45-BE57-43FF-93E2-E21FE390622CQ42224334-5B18BB35-1A13-4C59-B169-8D730993CE5FQ42224793-5BCB261E-7937-4E35-B293-66BFC841654BQ43853663-005E00D7-92E5-4FC9-BC10-1165E2F2E32AQ45769211-0891FFFF-B233-4137-ABCE-1FD739A09923
P2860
A comparison of hepatitis B seroepidemiology in ten European countries.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A comparison of hepatitis B seroepidemiology in ten European countries.
@en
type
label
A comparison of hepatitis B seroepidemiology in ten European countries.
@en
prefLabel
A comparison of hepatitis B seroepidemiology in ten European countries.
@en
P2093
P2860
P1476
A comparison of hepatitis B seroepidemiology in ten European countries
@en
P2093
A Hatzakis
B Bruzzone
C G Anastassopoulou
D O'Flanagan
P2860
P304
P356
10.1017/S0950268808001672
P577
2008-12-23T00:00:00Z